|
1
|
Crago AM, Denton B, Salas S, Dufresne A,
Mezhir JJ, Hameed M, Gonen M, Singer S and Brennan MF: A prognostic
nomogram for prediction of recurrence in desmoid fibromatosis. Ann
Surg. 258:347–353. 2013.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Mullen JT, Delaney TF, Kobayashi WK,
Szymonifka J, Yeap BY, Chen YL, Rosenberg AE, Harmon DC, Choy E,
Yoon SS, et al: Desmoid tumor: Analysis of prognostic factors and
outcomes in a surgical series. Ann Surg Oncol. 19:4028–4035.
2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Bonvalot S, Tzanis D and Bouhadiba T:
Desmoid tumors: Are there still any surgical indications? Bull
Cancer. 107:364–370. 2020.PubMed/NCBI View Article : Google Scholar : (In French).
|
|
4
|
He XD, Zhang YB, Wang L, Tian ML, Liu W,
Qu Q, Li BL, Hong T, Li NC and Na YQ: Prognostic factors for the
recurrence of sporadic desmoid-type fibromatosis after
macroscopically complete resection: Analysis of 114 patients at a
single institution. Eur J Surg Oncol. 41:1013–1019. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Devata S and Chugh R: Desmoid tumors: A
comprehensive review of the evolving biology, unpredictable
behavior, and myriad of management options. Hematol Oncol Clin
North Am. 27:989–1005. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Kummar S, O'Sullivan Coyne G, Do KT,
Turkbey B, Meltzer PS, Polley E, Choyke PL, Meehan R, Vilimas R,
Horneffer Y, et al: Clinical activity of the γ-secretase inhibitor
PF-03084014 in adults with desmoid tumors (aggressive
fibromatosis). Clin Oncol. 35:1561–1569. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Turner B, Alghamdi M, Henning JW, Kurien
E, Morris D, Bouchard-Fortier A, Schiller D, Puloski S, Monument M,
Itani D and Mack LA: Surgical excision versus observation as
initial management of desmoid tumors: A population based study. Eur
J Surg Oncol. 45:699–703. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Kasper B, Baumgarten C, Garcia J, Bonvalot
S, Haas R, Haller F, Hohenberger P, Penel N, Messiou C, van der
Graaf WT, et al: An update on the management of sporadic
desmoid-type fibromatosis: A european consensus initiative between
sarcoma PAtients EuroNet (SPAEN) and european organization for
research and treatment of cancer (EORTC)/soft tissue and bone
sarcoma group (STBSG). Ann Oncol. 28:2399–2408. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Lewis JJ, Boland PJ, Leung DH, Woodruff JM
and Brennan MF: The enigma of desmoid tumors. Ann Surg.
229:866–872. 1999.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Righetti AE, Jacomini C, Parra RS, de
Almeida AL, Rocha JJ and Féres O: Familial adenomatous polyposis
and desmoid tumors. Clinics (Sao Paulo). 66:1839–1842.
2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Samadder NJ, Baffy N, Giridhar KV, Couch
FJ and Riegert-Johnson D: Hereditary cancer syndromes-A primer on
diagnosis and management, part 2: Gastrointestinal cancer
syndromes. Mayo Clin Proc. 94:1099–1116. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Monahan KJ, Bradshaw N, Dolwani S, et al:
Guidelines for the management of hereditary colorectal cancer from
the British Society of Gastroenterology (BSG)/Association of
Coloproctology of Great Britain and Ireland (ACPGBI)/United Kingdom
Cancer Genetics Group (UKCGG)[J]. Gut. 69:411–444. 2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhenzhen W and Yaozong Y: Risk factors of
invasive fibroma in familial adenomatous polyposis. Chin J Dig.
34:640–642. 2014.
|
|
14
|
Nieuwenhuis MH, Mathus-Vliegen EM, Baeten
CG, Nagengast FM, van der Bijl J, van Dalsen AD, Kleibeuker JH,
Dekker E, Langers AM, Vecht J, et al: Evaluation of management of
desmoid tumours associated with familial adenomatous polyposis in
Dutch patients. Br J Cancer. 104:37–42. 2011.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Rutenberg MS, Indelicato DJ, Knapik JA,
Lagmay JP, Morris C, Zlotecki RA, Scarborough MT, Gibbs CP and
Marcus RB: External-beam radiotherapy for pediatric and young adult
desmoid tumors. Pediatr Blood Cancer. 57:435–442. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Gounder MM, Mahoney MR, Van Tine BA, Ravi
V, Attia S, Deshpande HA, Gupta AA, Milhem MM, Conry RM, Movva S,
et al: Sorafenib for advanced and refractory desmoid tumors. N Engl
J Med. 379:2417–2428. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Roussin S, Mazouni C, Rimareix F, Honoré
C, Terrier P, Mir O, Dômont J, Le Péchoux C, Le Cesne A and
Bonvalot S: Toward a new strategy in desmoid of the breast? Eur J
Surg Oncol. 41:571–576. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Bonvalot S, Eldweny H, Haddad V, Rimareix
F, Missenard G, Oberlin O, Vanel D, Terrier P, Blay JY, Le Cesne A
and Le Péchoux C: Extra-abdominal primary fibromatosis: Aggressive
management could be avoided in a subgroup of patients. Eur J Surg
Oncol. 34:462–468. 2008.PubMed/NCBI View Article : Google Scholar
|
